EXEL

3 Horrendous Health-Care Stocks This Week

moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is hiring next, click here to view […]

Talk About High Clinical Trial Expectations

moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is hiring next, click here to view […]

Exelixis Provides Update on Ongoing COMET-1 Phase 3 Pivotal Trial in Men with Metastatic Castration-Resistant Prostate Cancer

[Business Wire] – Exelixis, Inc. announced that the Independent Data Monitoring Committee notified the company today that a planned interim analysis of the COMET-1 phase 3 pivotal trial has been completed, and that the IDMC recommended the trial proceed moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is […]

1 Piece of News That Could Move Exelixis

moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is hiring next, click here to view […]

Exelixis Announces Webcast of March 4 Presentation at the 34th Annual Cowen and Company Health Care Conference

[Business Wire] – Exelixis, Inc. today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at the 34th Annual Cowen and Company Health Care Conference at 10:00 a.m. moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is hiring next, click here to view […]

EXELIXIS, INC. Financials

moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who Exelixis is hiring next, click here to view […]

Exelixis CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Mike Morrissey All right, thank you Charles and thanks to everyone for joining us on the call today. We’re off to a busy start in 2014 and continue to focus on our key clinical, commercial and financial … moreView todays social media effects on EXELView the latest stocks trending across Twitter. Click to view dashboardSee who […]